Brightworth Invests $220,000 in Danaher Co. (DHR)

Brightworth acquired a new stake in Danaher Co. (NYSE:DHR) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 1,663 shares of the conglomerate’s stock, valued at approximately $220,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Laurel Wealth Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter worth about $27,000. CX Institutional lifted its stake in shares of Danaher by 188.7% during the 1st quarter. CX Institutional now owns 205 shares of the conglomerate’s stock worth $27,000 after buying an additional 134 shares during the last quarter. Hanson McClain Inc. lifted its stake in shares of Danaher by 852.9% during the 4th quarter. Hanson McClain Inc. now owns 324 shares of the conglomerate’s stock worth $33,000 after buying an additional 290 shares during the last quarter. Executive Wealth Management LLC acquired a new stake in shares of Danaher during the 4th quarter worth about $39,000. Finally, Ruggie Capital Group acquired a new stake in shares of Danaher during the 4th quarter worth about $40,000. 77.60% of the stock is owned by institutional investors.

Shares of Danaher stock opened at $130.93 on Monday. Danaher Co. has a twelve month low of $94.59 and a twelve month high of $134.50. The company has a quick ratio of 1.07, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $93.74 billion, a price-to-earnings ratio of 28.97, a price-to-earnings-growth ratio of 2.53 and a beta of 1.04.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.06. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The business had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter in the previous year, the company earned $0.99 EPS. The business’s revenue was up 3.9% on a year-over-year basis. As a group, equities research analysts expect that Danaher Co. will post 4.76 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, April 26th. Shareholders of record on Friday, March 29th were issued a $0.17 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.16. This represents a $0.68 annualized dividend and a yield of 0.52%. The ex-dividend date of this dividend was Thursday, March 28th. Danaher’s dividend payout ratio (DPR) is currently 15.04%.

In other Danaher news, Director Walter G. Lohr sold 10,578 shares of the firm’s stock in a transaction dated Wednesday, February 27th. The shares were sold at an average price of $126.85, for a total value of $1,341,819.30. Following the transaction, the director now directly owns 20,691 shares of the company’s stock, valued at approximately $2,624,653.35. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Alan G. Spoon sold 1,913 shares of the firm’s stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total transaction of $247,771.76. Following the completion of the transaction, the director now directly owns 86,863 shares in the company, valued at $11,250,495.76. The disclosure for this sale can be found here. Over the last three months, insiders sold 185,063 shares of company stock worth $23,527,408. Insiders own 11.40% of the company’s stock.

A number of analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, April 23rd. Needham & Company LLC reiterated a “buy” rating and issued a $141.00 price objective (up previously from $138.00) on shares of Danaher in a research note on Wednesday, April 17th. Jefferies Financial Group lifted their price objective on shares of Danaher to $140.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Deutsche Bank lifted their price objective on shares of Danaher to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Finally, Janney Montgomery Scott lifted their price objective on shares of Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research note on Wednesday, April 17th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Danaher currently has a consensus rating of “Buy” and a consensus price target of $131.75.

ILLEGAL ACTIVITY NOTICE: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://sportsperspectives.com/2019/04/29/brightworth-invests-220000-in-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: How to calculate compound interest

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.